Schedule 13G ownership disclosure

CYTOTHERAPEUTICS INC/DE

Security class unavailable

Event date: 2017-06-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,078,214
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-17-006651
Form type
SC 13G
Filer
Lewkowicz Leon
CIK
CIK 1690590
Filed
Jun 20, 2017
Reporting period
Jun 16, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub